https://www.selleckchem.com/pr....oducts/alflutinib-as
No hematoma recurrence has since been experienced. Recurrent SEDH is relatively rare, with only 11 cases previously reported. Recurrent hematoma cases are more common in young, female patients, while SEDH, in general, is more common in males in their late forties. The recurrence interval is shorter in non-surgical cases than those requiring surgery. Knowledge of these characteristics may be useful in the future management of SEDH.Cerebral hyperperfusion syndrome (CHS) is a potentially devastating complication of caro